Vor Biopharma (NASDAQ:VOR – Get Free Report) announced its earnings results on Tuesday. Vor Biopharma Stock PerformanceShares of VOR traded down $0.39 during trading hours on Tuesday, hitting $22.98. Get Vor Biopharma alerts:Analyst Ratings ChangesSeveral equities research analysts have weighed in on VOR shares. Finally, Susquehanna Portfolio Strategies LLC acquired a new position in Vor Biopharma during the 4th quarter valued at about $134,000. Featured StoriesReceive News & Ratings for Vor Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vor Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.